PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE: payments to doctors
Payments that named PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $937K
- Providers
- 2
- Transactions
- 18
- Average per transaction
- $52,063
The per-transaction average — $52,063 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2 providers the average total is $468,565, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Affordable Pharmaceuticals, LLC | $737,233 | 78.7% |
| Braintree Laboratories, Inc. | $199,896 | 21.3% |